Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 6
2008 4
2009 4
2010 5
2011 6
2012 16
2013 12
2014 8
2015 7
2017 1
2018 1
2019 2
2020 1
2021 1
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Fenofibrate and the kidney: an overview.
Kostapanos MS, Florentin M, Elisaf MS. Kostapanos MS, et al. Eur J Clin Invest. 2013 May;43(5):522-31. doi: 10.1111/eci.12068. Epub 2013 Mar 11. Eur J Clin Invest. 2013. PMID: 23480615 Review.
Therapeutic options for statin-intolerant patients.
Kostapanos MS, Athyros VG, Karagiannis A, Mikhailidis DP. Kostapanos MS, et al. Curr Med Res Opin. 2012 Mar;28(3):345-9. doi: 10.1185/03007995.2012.657757. Epub 2012 Jan 31. Curr Med Res Opin. 2012. PMID: 22292417 No abstract available.
Hemostatic factors and the metabolic syndrome.
Kostapanos MS, Florentin M, Elisaf MS, Mikhailidis DP. Kostapanos MS, et al. Curr Vasc Pharmacol. 2013 Nov;11(6):880-905. doi: 10.2174/15701611113116660171. Curr Vasc Pharmacol. 2013. PMID: 24168445 Review.
Pioglitazone and cancer: angel or demon?
Kostapanos MS, Elisaf MS, Mikhailidis DP. Kostapanos MS, et al. Curr Pharm Des. 2013;19(27):4913-29. doi: 10.2174/13816128113199990294. Curr Pharm Des. 2013. PMID: 23278487 Review.
Statins and their increased risk of inducing diabetes.
Agouridis AP, Kostapanos MS, Elisaf MS. Agouridis AP, et al. Among authors: kostapanos ms. Expert Opin Drug Saf. 2015;14(12):1835-44. doi: 10.1517/14740338.2015.1096343. Epub 2015 Oct 5. Expert Opin Drug Saf. 2015. PMID: 26437128 Review.
Emerging drugs for hyperlipidaemia: an update.
Florentin M, Kostapanos MS, Kei A, Elisaf MS. Florentin M, et al. Among authors: kostapanos ms. Expert Opin Emerg Drugs. 2014 Dec;19(4):471-88. doi: 10.1517/14728214.2014.976553. Epub 2014 Oct 30. Expert Opin Emerg Drugs. 2014. PMID: 25356785 Review.
70 results